Colab Platforms Limited has formally notified BSE Limited about an upcoming board meeting scheduled for February 13, 2026, to deliberate on the company's third quarter financial performance for FY26. The announcement, made on February 5, 2026, outlines the key agenda items and regulatory compliance measures associated with the financial results disclosure.

Board Meeting Agenda

The Board of Directors will convene at the company's registered office to address several critical matters related to the quarterly financial disclosure. The meeting agenda encompasses both standalone and consolidated financial results review, along with statutory compliance requirements.

Statutory Compliance and Auditor Review

The board meeting will also focus on the limited review report to be issued by the company's statutory auditors regarding the unaudited financial results. This review process ensures compliance with regulatory standards and provides additional assurance on the financial data being presented to stakeholders.

Additional business matters may be considered during the meeting, subject to the Chairman's permission, allowing for flexibility in addressing any urgent corporate matters that may arise.

Trading Window Restrictions

Colab Platforms Limited has implemented a trading window closure effective January 1, 2026, in accordance with insider trading regulations. This restriction will remain in place until 48 hours after the official announcement of financial results for the quarter and nine months ended December 31, 2025.

The trading window closure demonstrates the company's commitment to maintaining fair market practices and preventing any potential insider trading activities during the sensitive period leading up to financial results disclosure.

Regulatory Framework

The board meeting notification has been issued under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to inform stock exchanges about board meetings where financial results will be considered, ensuring transparency and timely disclosure to market participants.

The announcement was signed by Puneet Singh Chandhok, Managing Director (DIN: 01546843), confirming the official nature of the communication and the company's adherence to corporate governance standards.

Colab Platforms Limited has received board approval to list its equity shares on the Metropolitan Stock Exchange of India Limited (MSEI), marking a significant step in expanding its stock exchange presence. The decision was unanimously approved during a board meeting held on January 22, 2026.

Board Meeting Details

The board meeting was conducted at the company's registered office and chaired by Managing Director Puneet Singh Chandhok. The meeting proceedings were efficiently managed within a 30-minute timeframe.

Key Resolution Approved

The primary agenda item addressed during the meeting focused on expanding the company's stock exchange listing footprint. The board formally approved the listing of Colab Platforms Limited's equity shares on MSEI, demonstrating the company's commitment to enhancing market accessibility for investors.

The approval comes with standard regulatory conditions that must be fulfilled before the listing becomes effective. These include obtaining necessary approvals from relevant authorities, securing required consents, and ensuring compliance with all applicable regulations and requirements.

Regulatory Compliance

The announcement was made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to disclose material events and information that could impact investor decisions.

Colab Platforms Limited is currently listed on BSE Limited under the script code 542866 and script ID COLAB. The addition of MSEI listing would provide investors with an additional platform for trading the company's shares, potentially improving liquidity and market reach.

Next Steps

The company will now proceed with the necessary regulatory processes to complete the MSEI listing. This includes submitting applications to relevant authorities, fulfilling documentation requirements, and ensuring compliance with MSEI's listing norms and procedures. The timeline for completing the listing process will depend on regulatory approvals and the fulfillment of all prescribed conditions.